A Trial of Ipatasertib in Combination With Atezolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
IA Carboplatin + Radiotherapy in Relapsing GBM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MRI Predictors of Response to Tumor Treating Fields
- Status
- UNKNOWN
- Phase
- N/A
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
- Status
- COMPLETED
- Phase
- NA
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PreOperative Brain Irradiation in Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
3D Prediction of Patient-Specific Response
- Status
- UNKNOWN
- Phase
- N/A
Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
UNITE Study: Understanding New Interventions With GBM ThErapy
- Status
- TERMINATED
- Phase
- PHASE3
Multi-site Validation and Application of a Consensus DSC-MRI Protocol
- Status
- UNKNOWN
- Phase
- NA
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
- Status
- UNKNOWN
- Phase
- N/A
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE2
Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Phase I EGFR BATs in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
- Status
- TERMINATED
- Phase
- PHASE1